Bridgeway Capital Management, LLC Bioventus Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.33 - $5.75 $216,500 - $287,500	-50,000 Reduced 13.74%	313,804 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$0.93 - $3.64 $57,097 - $223,477	61,395 Added 20.3%	363,804 $1.05 Million
Q1 2023 May 15, 2023	BUY	$1.07 - $2.95 $161,682 - $445,759	151,105 Added 99.87%	302,409 $323,000
Q4 2022 Feb 14, 2023	BUY	$1.81 - $8.14 $273,860 - $1.23 Million	151,304 New	151,304 $394,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $619M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.